Overactivity of AKT signaling occurs in many cancers, especially in brain tumors [3], and is prominent in gliomas, where it has been associated with tumor progression, recurrence, radioresistance, and poor survival [4]. This evidence concerns the gene AKT1 and central nervous system cancer.